REPORT ID 10214

Global Ophthalmic Therapeutic Drugs Market Research Report 2017

Publish Date
16-Nov-17
Pages
100
Format
Electronic (PDF)

In this report, the global Ophthalmic Therapeutic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Ophthalmic Therapeutic Drugs in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Ophthalmic Therapeutic Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Bayer
    Pfizer
    Novartis
    ALLERGAN
    Aerie Pharmaceuticals
    Valeant Pharmaceuticals International
    Genentech
    Regeneron Pharmaceuticals
    Shire
    Santen Pharmaceutical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    by Therapeutic Class
        Anti-inflammatory Drugs
        Anti-infective Drugs
        Anti-glaucoma Drugs
        Anti-allergy Drugs
        Anti-VEGF Agents
        Others
    by Product Type
        Prescription Drugs
        Over-the-Counter Drugs
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospital Pharmacies
    Online Pharmacies
    Independent Pharmacies & Drug Stores

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Ophthalmic Therapeutic Drugs Market Research Report 2017
1 Ophthalmic Therapeutic Drugs Market Overview
    1.1 Product Overview and Scope of Ophthalmic Therapeutic Drugs
    1.2 Ophthalmic Therapeutic Drugs Segment by Therapeutic Class
        1.2.1 Global Ophthalmic Therapeutic Drugs Production and CAGR (%) Comparison by Therapeutic Class (Product Category)(2012-2022)
        1.2.2 Global Ophthalmic Therapeutic Drugs Production Market Share by Therapeutic Class (Product Category) in 2016
        1.2.3 Anti-inflammatory Drugs
        1.2.4 Anti-infective Drugs
        1.2.5 Anti-glaucoma Drugs
        1.2.6 Anti-allergy Drugs
        1.2.7 Anti-VEGF Agents
        1.2.8 Others
    1.3 Ophthalmic Therapeutic Drugs Segment by Product Type
        1.3.1 Prescription Drugs
        1.3.2 Over-the-Counter Drugs
    1.4 Global Ophthalmic Therapeutic Drugs Segment by Application
        1.4.1 Ophthalmic Therapeutic Drugs Consumption (Sales) Comparison by Application (2012-2022)
        1.4.2 Hospital Pharmacies
        1.4.3 Online Pharmacies
        1.4.4 Independent Pharmacies & Drug Stores
    1.5 Global Ophthalmic Therapeutic Drugs Market by Region (2012-2022)
        1.5.1 Global Ophthalmic Therapeutic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.5.2 North America Status and Prospect (2012-2022)
        1.5.3 Europe Status and Prospect (2012-2022)
        1.5.4 China Status and Prospect (2012-2022)
        1.5.5 Japan Status and Prospect (2012-2022)
        1.5.6 Southeast Asia Status and Prospect (2012-2022)
        1.5.7 India Status and Prospect (2012-2022)
    1.6 Global Market Size (Value) of Ophthalmic Therapeutic Drugs (2012-2022)
        1.6.1 Global Ophthalmic Therapeutic Drugs Revenue Status and Outlook (2012-2022)
        1.6.2 Global Ophthalmic Therapeutic Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Ophthalmic Therapeutic Drugs Market Competition by Manufacturers
    2.1 Global Ophthalmic Therapeutic Drugs Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Ophthalmic Therapeutic Drugs Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Ophthalmic Therapeutic Drugs Production and Share by Manufacturers (2012-2017)
    2.2 Global Ophthalmic Therapeutic Drugs Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Ophthalmic Therapeutic Drugs Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Ophthalmic Therapeutic Drugs Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Ophthalmic Therapeutic Drugs Market Competitive Situation and Trends
        2.5.1 Ophthalmic Therapeutic Drugs Market Concentration Rate
        2.5.2 Ophthalmic Therapeutic Drugs Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Ophthalmic Therapeutic Drugs Capacity and Market Share by Region (2012-2017)
    3.2 Global Ophthalmic Therapeutic Drugs Production and Market Share by Region (2012-2017)
    3.3 Global Ophthalmic Therapeutic Drugs Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Ophthalmic Therapeutic Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Ophthalmic Therapeutic Drugs Consumption by Region (2012-2017)
    4.2 North America Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)
    4.4 China Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)
    4.7 India Ophthalmic Therapeutic Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Ophthalmic Therapeutic Drugs Production, Revenue (Value), Price Trend by Type
    5.1 Global Ophthalmic Therapeutic Drugs Production and Market Share by Type (2012-2017)
    5.2 Global Ophthalmic Therapeutic Drugs Revenue and Market Share by Type (2012-2017)
    5.3 Global Ophthalmic Therapeutic Drugs Price by Type (2012-2017)
    5.4 Global Ophthalmic Therapeutic Drugs Production Growth by Type (2012-2017)

6 Global Ophthalmic Therapeutic Drugs Market Analysis by Application
    6.1 Global Ophthalmic Therapeutic Drugs Consumption and Market Share by Application (2012-2017)
    6.2 Global Ophthalmic Therapeutic Drugs Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Ophthalmic Therapeutic Drugs Manufacturers Profiles/Analysis
    7.1 Bayer
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Bayer Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Pfizer
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Pfizer Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Novartis
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Novartis Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 ALLERGAN
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 ALLERGAN Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Aerie Pharmaceuticals
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Aerie Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Valeant Pharmaceuticals International
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Valeant Pharmaceuticals International Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Genentech
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Genentech Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Regeneron Pharmaceuticals
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Regeneron Pharmaceuticals Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Shire
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Shire Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Santen Pharmaceutical
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Ophthalmic Therapeutic Drugs Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Santen Pharmaceutical Ophthalmic Therapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Ophthalmic Therapeutic Drugs Manufacturing Cost Analysis
    8.1 Ophthalmic Therapeutic Drugs Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Ophthalmic Therapeutic Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Ophthalmic Therapeutic Drugs Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Ophthalmic Therapeutic Drugs Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Ophthalmic Therapeutic Drugs Market Forecast (2017-2022)
    12.1 Global Ophthalmic Therapeutic Drugs Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Ophthalmic Therapeutic Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Ophthalmic Therapeutic Drugs Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Ophthalmic Therapeutic Drugs Price and Trend Forecast (2017-2022)
    12.2 Global Ophthalmic Therapeutic Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Ophthalmic Therapeutic Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Ophthalmic Therapeutic Drugs Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Ophthalmic Therapeutic Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer